Autologous Umbilical Cord Blood Transfusion for Preterm Neonates

Study Description

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

This is a pilot study to test feasibility of collection, preparation and infusion of a baby's own (autologous) umbilical cord blood in the first 14 days after birth if the baby is born premature <35 weeks of gestation.

Condition or disease	Intervention/treatment	Phase
Prematurity; Respiratory Distress Syndrome; Anemia of Prematurity; Intraventricular Hemorrhage	Biological: Autologous cord blood transfusion for preterm neonates; Biological: Autologous cord blood transfusion	Phase 1

Detailed Description:

In Egypt, 12-15.8% of live neonates are low birth weight and it is estimated that about one third of such infants are preterm [1] (UNICEF, 2001). In a study that Campbell et al. (2004) conducted in Egypt, the neonatal mortality rate was estimated to be 25 per 1000 live births. prematurity was considered the main cause of neonatal deaths (39%), followed by asphyxia (18%), infection (7%), especially in the late neonatal period, and congenital malformations (6%). A substantial proportion (29%) could not be classified [2]. In developing countries, prematurity was the main cause of early neonatal deaths (62%)[3] Autologous cord blood transfusion will be safe, and cheap. The preterm neonates need transfusion of whole blood or any of its components at a time during NICU admission.

Study Design

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Interventional (Clinical Trial)
Estimated Enrollment :	60 participants
Allocation:	Non-Randomized
Intervention Model:	Single Group Assignment
Masking:	None (Open Label)
Primary Purpose:	Supportive Care
Official Title:	Autologous Umbilical Cord Blood Transfusion for Preterm and Low Birth Weight Neonates: A Pilot Feasibility Study
Study Start Date :	July 2011
Estimated Primary Completion Date :	March 2014
Estimated Study Completion Date :	September 2014

Arms and Interventions

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm

Intervention/treatment

Experimental: Autologous cord blood transfusion; Collected cord blood at birth will be transfused for the preterm neonate

Biological: Autologous cord blood transfusion for preterm neonates; Cord blood collection after delivery of the baby. Preservation of blood in blood bank. Transfusion of blood within the first 14 postnatal days to maintain Hb level above 10gm%.; Other Name: Transfusion blood bag collection. Biological: Autologous cord blood transfusion; After delivery of the baby and before placental delivery in vaginal delivery. After delivery of the baby the placental will be taken out in cesarean section. sterilization of the umbilical cord will be done. Puncture of the umbilical cord vein with the needle of blood transfusion bag will be done. Blood will be kept in the blood bank. Blood grouping, haematocrit and CBC will be done for the cord blood.Maternal sample will be analysed simultaneously. Mononuclear layer will be separated within 6 hours and transfused to the preterm neonate immediately. RBCs will be separated and kept till need (Hb less than 10 gm%).; Other Name: Cord blood transfusion for preterm neonates

Outcome Measures

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :

1. Duration of mechanical ventilation [ Time Frame: 30 days ]
   -No need for mechanical ventilation.

Secondary Outcome Measures :

1. Survival [ Time Frame: 18 months ]
   • Survival until 12 months of age.
   • Improved physical growth and weight gain.
   • Neurodevelopmental outcome at 6, 12 and 18 months of age.

Eligibility Criteria

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	up to 30 Days (Child)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

• Preterm neonates less than 34 weeks of gestation.
• Low birth weight less than 1500 grams

Exclusion Criteria:

• Congenital malformations.
• Suspected inborn error of metabolism.
• Suspected inherited neurologic disease.

Contacts and Locations

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Contacts

Contact: Dr. Sahar MA Hassanein, MD	+20123183943	saharhassanein@med.asu.edu.eg

Locations

Egypt
Children's Hospital, Faculty of Medicine, Ain Shams University	Recruiting
Cairo, Egypt, 11381
Contact: Mohsen Elalfy, MD +201000864343
Principal Investigator: Prof. Dr. Sahar MA Hassanein, MD

Sponsors and Collaborators

Sahar M.A. Hassanein, MD

Investigators

Principal Investigator:	Prof. Sahar MA Hassanein, MD	Children's Hospital, Faculty of Medicine, Ain Shams University

More Information

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party:	Sahar M.A. Hassanein, MD, Professor of Pediatrics, Children's Hospital, Faculty of Medicine, Ain Shams University
ClinicalTrials.gov Identifier:	NCT01121328 History of Changes
Other Study ID Numbers:	IRB#1
First Posted:	May 12, 2010
Last Update Posted:	April 26, 2013
Last Verified:	April 2013

Keywords provided by Sahar M.A. Hassanein, MD, Ain Shams University:

Preterm neonates.; Autologous cord blood transfusion.

Additional relevant MeSH terms:

Hemorrhage; Respiratory Distress Syndrome, Newborn; Respiratory Distress Syndrome, Adult; Premature Birth; Cerebral Hemorrhage; Pathologic Processes; Lung Diseases; Respiratory Tract Diseases; Respiration Disorders; Infant, Premature, Diseases; Infant, Newborn, Diseases	Obstetric Labor, Premature; Obstetric Labor Complications; Pregnancy Complications; Intracranial Hemorrhages; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases